Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions

Healthy

Interventions

DRUG

Amaryl-M 2/500 mg

single oral administration in period 2 for TR sequential group, and in period 1 for RT sequential group, respectively

DRUG

Amaryl-M 1/500 mg

single oral administration in period 1 for TR sequential group, and in period 2 for RT sequential group, respectively